(Q46485907)

22 December 2017

title

The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients (English)

1 reference

22 December 2017

1 reference

Serpil Erdogan

1

1 reference

22 December 2017

Halef Okan Dogan

2

1 reference

22 December 2017

Sevilay Sezer

3

1 reference

22 December 2017

Sema Uysal

4

1 reference

22 December 2017

Esra Ozhamam

5

1 reference

22 December 2017

Serra Kayacetin

6

1 reference

22 December 2017

Yuksel Koca

7

1 reference

22 December 2017

publication date

20 March 2013

1 reference

22 December 2017

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

22 December 2017

volume

73

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

300-308

1 reference

22 December 2017

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Evaluation of the patient with hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Fibrosis in chronic liver diseases: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Routine blood tests to predict liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2013.773592

10.3109/00365513.2013.773592

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017